Profit and Loss
2025 formulated accounts (board approved 4 May 2026)
- Revenue (cifra de negocios): €604,495 (+85% YoY vs €326,208 in 2024)
- Capitalised internal R&D: €632,058
- Personnel expenses: −€1,346,107 (+28% YoY)
- Result for the year: −€517,357 (vs +€244,512 profit in 2024)
- Result allocation: applied against prior-year results (account 121)
Looking for a download?
You can access the document Seed round Financial Projections Legit.Health and download, like this: